Makers Pull Cough Medicine For Infants

The makers of cough and cold medicines for infants have pulled several products off shelves, but an industry group said the move is out of caution, not to fix a safety issue.

An industry group noted that the Food and Drug Administration has not called for a ban or recall of the products.

The medicines included in the action are:

Dimetapp Decongestant Plus Cough Infant Drops

Dimetapp Decongestant Infant Drops

Little Colds Decongestant Plus Cough

Little Colds Multi-Symptom Cold Formula

Pediacare Infant Drops Decongestant (containing pseudoephedrine)

Pediacare Infant Drops Decongestant Cough (containing pseudoephedrine)

Pediacare Infant Dropper Decongestant (containing phenylephrine)

Pediacare Infant Dropper Long-Acting Cough

Pediacare Infant Dropper Decongestant & Cough (containing phenylephrine)

Robitussin Infant Cough DM Drops

Triaminic Infant & Toddler Thin Strips Decongestant

Triaminic Infant & Toddler Thin Strips Decongestant Plus Cough

Tylenol Concentrated Infants' Drops Plus Cold

Tylenol Concentrated Infants' Drops Plus Cold & Cough

The Consumer Healthcare Products Association said the medicines are safe and effective when used at the right doses.

Information online also pointed out that labels say people should check with doctors before giving medicine to children under age 2, who are most vulnerable to overdoses. Makers have asked the FDA to change the labels to say the medicines should not be given to infants.

The industry said it plans an education effort to let caregivers know how to safely use over-the-counter medications.